NewslettersMammary Cell NewsBreast Cancer Cells Survive Chemotherapy by Activating Targetable Immune-Modulatory Programs Characterized by PD-L1 or CD80By Noshin Noorjahan - December 15, 20220649Investigators showed that breast tumors surviving chemotherapy activate complex programs of immune modulation. Characterization of residual disease revealed distinct tumor cell populations.[Nature Cancer]Abstract